🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study employs a multicenter, randomized, open-label, positive drug-con...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-01
Trial ID
NCT06854276
This study will assess the efficacy and safety of intravenous R744 in renal...
Status
Completed
Location
Chugoku/Shikoku region
Start Date
2007-01
Trial ID
NCT00433888
To evaluate the safety, tolerance and biological activity of filgrastim (gr...
Status
Completed
Location
UCLA Med Ctr
Start Date
TBD
Trial ID
NCT00002281
Treatments Being Tested
Epo increases red blood cell production and hence the amount of oxygen that...
Status
Completed
Location
Aarhus University Hospital
Start Date
2011-08
Trial ID
NCT01320449
Treatments Being Tested
A phase 2, randomized, open label, active comparator parallel controlled st...
Status
Unknown
Location
The general hospital of the people's liberation army
Start Date
2019-06-24
Trial ID
NCT03950687
This was a multicenter, randomized, open label, non inferiority clinical st...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05
Trial ID
NCT06946394
Treatments Being Tested
Sarcopenia, abbreviated as muscle loss, is a prevalent complication among p...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-10
Trial ID
NCT07162090
Treatments Being Tested
An investigator-blinded, randomized, multicenter, active-controlled Phase I...
Status
Recruiting
Location
"ARABKIR" Joint Medical Center & Institute of Child and Adolescent Health
Start Date
2024-01-25
Trial ID
NCT06466785
Treatments Being Tested
This study used as the comparative drug (epoetin beta) will assess the effi...
Status
Completed
Location
Chugoku/Shikoku region
Start Date
2007-06
Trial ID
NCT00491868
Treatments Being Tested
Open label and monocentric Phase I Clinical Trial, to Determine the Pharmac...
Status
Not Yet Recruiting
Location
Azidus Laboratories
Start Date
2024-10-06
Trial ID
NCT04954989